carcinoembryon antigen cystic fibrosi protein blood cystic fibrosi homozygot heterozygot carrier carcinoembryon antigen cea activ measur radioimmunoassay blood cystic fibrosi cf homozygot heterozygot carrier cf normal healthi control patient control carcinoma involv gastrointestin organ sampl also screen electrofocus cystic fibrosi protein cfp metabol marker previous shown associ cf gene significantli increas level cea activ found cfpposit group howev one except patient control mark increas cea activ cfp neg immunodiffus perchlor acid extract cealik materi heterozygot carrier blood indic cealik materi elev homozygot heterozygot cf show partial ident two separ cea prepar obtain colon carcinoma ident either b oh blood group substanc glycoprotein materi howev react three differ anticea antisera find abnorm increas glycoprotein cystic fibrosi taken togeth previou report demonstr abnorm carbohydr portion glycoprotein found variou exocrin secret cf suggest primari defect diseas manifest partli defect glycoprotein metabol defect may result abnorm one glycosyltransferas possibl caus primari defect polyamin metabol